Industrial Machinery & Robotics Global On demand · 24-48h

Global Laboratory Pipetting Robot Market Strategic Research Report

Global Laboratory Pipetting Robot Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Laboratory Pipetting Robot Market
$9172025
6.8%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Semi-automatic, Fully Automatic

By Application: Sample Preparation, Cell Culture, Diagnostics, Drug R&D, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Flow Robotic, BRANDTECH Scientific, Integra Biosciences, Waters Corporation, HighRes Biosolutions, Bio Molecular Systems (BMS), Endress+Hauser, Zinsser, Opentrons, Beckman Coulter, Eppendorf, Hamilton, Qinstruments(BICO), Gilson, Formulatrix, Aurora Biomed, Tecan Group, Agilent Technologies, Hudson Robotics, Mettler Toledo, MGI Tech, Shanghai Benyou Technology, Shenzhen MGI Tech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 153 pages
Market size 2025
$917
Million USD
Forecast CAGR
6.8%
2025-2032
Forecast 2032
$1453.3
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Laboratory Pipetting Robot market size is predicted to grow from US$ 917 million in 2025 to US$ 1,454 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.

In 2025, global Laboratory Pipetting Robot production reached approximately 97.5 k units with an average global market price of around k US$96 per unit. Single-line annual production capacity averages 9,000 units with a gross margin of approximately 27-32%. The upstream of Laboratory Pipetting Robots is concentrated in the fields of precision machinery and electronic components, primarily including motors, sensors, and control systems; the downstream applications are extensive, with sample preparation accounting for about 40%, cell culture materials for about 30%, diagnostics for about 20%, drug discovery for about 10%, and other fields for about 10%. With the rapid development of life sciences and pharmaceutical research and development, the demand for Laboratory Pipetting Robots continues to grow. Under the trend of laboratory automation, the market potential for Laboratory Pipetting Robots is considerable, especially in the fields of precision medicine and personalized therapy.

The Laboratory Pipetting Robot is a sophisticated system designed to enhance the efficiency and accuracy of liquid handling tasks within the confines of a laboratory setting. It is equipped with advanced mechanisms capable of automating a range of pipetting operations, from precise volume measurements to the dispensing of fluids into various containers. The robot's ability to execute these tasks consistently and repeatedly ensures the integrity of experimental results, while its user-friendly interface simplifies the programming and operation of complex pipetting sequences. The system is adaptable to different laboratory layouts and can be integrated with existing laboratory equipment, thereby optimizing workflow and reducing the potential for human error in critical laboratory processes.

In the future, the Laboratory Pipetting Robot industry will witness significant strides in technological innovation and system integration, driven by advancements in artificial intelligence, the Internet of Things, and intelligent automation. These robots will achieve higher precision and reliability, catering to the demands of high-accuracy experiments in the fields of life sciences and pharmaceutical research and development. Simultaneously, user interfaces will become more intuitive and user-friendly, enhancing compatibility and flexibility to adapt to various laboratory layouts and experimental procedures. With cost reduction and the provision of customized services, Laboratory Pipetting Robots will become more accessible, capable of accommodating different types of liquids and experimental requirements. Moreover, robots will adopt environmentally friendly designs to minimize environmental impact, and will adhere to global standards and regulations for laboratory equipment and experimental processes. As the market globalizes and regulatory compliance is enhanced, Laboratory Pipetting Robots will become an indispensable tool in research laboratories, propelling advancements in precision medicine and personalized therapy.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Laboratory Pipetting Robot market?

What factors are driving Laboratory Pipetting Robot market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Laboratory Pipetting Robot market opportunities vary by end market size?

How does Laboratory Pipetting Robot break out by Type, by Application?

This report presents a comprehensive overview of the global Laboratory Pipetting Robot market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Semi-automatic
  • Fully Automatic

Segment by Channel Number

  • Single Channel
  • Multi-channel

Segment by Consumables & Liquid Handling Mode

  • Tip-based Pipetting
  • Tipless Pipetting

Segment by Application

  • Sample Preparation
  • Cell Culture
  • Diagnostics
  • Drug R&D
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Laboratory Pipetting Robot market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Sample Preparation, Cell Culture, Diagnostics evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Laboratory Pipetting Robot Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.8%
Regional growth momentum
Market share by segment
Key metrics
Base value
$917
2025
Forecast
$1453.3
2032
CAGR
6.8%
2025–2032
区域
5
global
Key companies
Flow RoboticBRANDTECH ScientificIntegra BiosciencesWaters CorporationHighRes BiosolutionsBio Molecular Systems (BMS)Endress+HauserZinsser
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Semi-automaticFully Automatic
By Application
Sample PreparationCell CultureDiagnosticsDrug R&DOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Semi-automatic
  • 3.1.3 Fully Automatic
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Sample Preparation
  • 4.1.3 Cell Culture
  • 4.1.4 Diagnostics
  • 4.1.5 Drug R&D
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Flow Robotic
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 BRANDTECH Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Integra Biosciences
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Waters Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 HighRes Biosolutions
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bio Molecular Systems (BMS)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Endress+Hauser
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Zinsser
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Opentrons
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Beckman Coulter
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Eppendorf
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Hamilton
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Qinstruments(BICO)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Gilson
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Formulatrix
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Aurora Biomed
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Tecan Group
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Agilent Technologies
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Hudson Robotics
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Mettler Toledo
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 MGI Tech
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Shanghai Benyou Technology
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Shenzhen MGI Tech
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Laboratory Pipetting Robot market size?
The global Laboratory Pipetting Robot market is estimated at US$ 917 million in 2025 (base year) and is projected to reach US$ 1.45 billion by 2032.
What growth rate is expected for the Laboratory Pipetting Robot market through 2032?
The market is expected to grow at a CAGR of 6.8% from 2026 to 2032, expanding from US$ 917 million in 2025 to US$ 1.45 billion in 2032, roughly 1.6 times its base-year value.
How is Laboratory Pipetting Robot defined?
In 2025, global Laboratory Pipetting Robot production reached approximately 97.5 k units with an average global market price of around k US$96 per unit. Single-line annual production capacity averages 9,000 units with a gross margin of approximately 27-32%.
How is the Laboratory Pipetting Robot market segmented by type?
By type, the market is segmented into Semi-automatic and Fully Automatic.
What are the key applications of Laboratory Pipetting Robot?
Key applications covered include Sample Preparation, Cell Culture, Diagnostics, Drug R&D and Others.
Which companies are profiled in the Laboratory Pipetting Robot market report?
Key players profiled include Flow Robotic, BRANDTECH Scientific, Integra Biosciences, Waters Corporation, HighRes Biosolutions, Bio Molecular Systems (BMS), Endress+Hauser and Zinsser, among 23 companies covered in total.
What geographies does the Laboratory Pipetting Robot market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Laboratory Pipetting Robot?
In the future, the Laboratory Pipetting Robot industry will witness significant strides in technological innovation and system integration, driven by advancements in artificial intelligence, the Internet of Things, and intelligent automation.
Who should buy the Laboratory Pipetting Robot market report?
The report is intended for manufacturers and solution providers, distributors and end users in Sample Preparation, Cell Culture and Diagnostics, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Laboratory Pipetting Robot market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.